Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Burcon Nutrascience (TSE:BU)
TSX:BU
Holding TSE:BU?
Track your performance easily
Earnings Data
Report Date
Feb 18, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
>-0.01Last Year’s EPS
-0.02Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 12, 2019
|% Change Since: -30.43%
|Next Earnings Date:Aug 10, 2018
Earnings Call Sentiment|Neutral
The earnings call presented a transformative strategy with an innovative business model and strong market demand, but historical challenges and recent financial metrics raise concerns.Company Guidance
During the Burcon NutraScience Corporation Q2 2025 earnings call, the company provided several key metrics and guidance for the upcoming periods. The company aims to raise up to $12 million through a rights offering, with the proceeds intended to fund operations at a new facility and achieve a cash flow positive state. Burcon plans to begin commercial production in the first half of 2025, with the acquisition of a production facility expected to close in Q1 2025. The company anticipates launching its entire portfolio, including sunflower protein, and projects profitability by calendar 2026. They also reported a robust sales pipeline with over 80 potential customers interested in their protein isolates. Burcon underscored its strategic shift towards a capital-light, high-margin business model, emphasizing the transformative potential of their new production and market strategies.Innovative Business Model and Strategic Alliance
Burcon plans to acquire a production facility with a strategic buying group, allowing full control over production and sale, leveraging a capital-light model.
Rights Offering and Fundraising
Burcon announced a rights offering aiming to raise up to $12 million to fund operations and achieve cash flow positive status.
Strong Market Demand for Plant Proteins
There is significant demand for plant proteins, with over 80 potential customers interested in Burcon's isolates.
Sunflower Protein as a Disruptive Technology
Sunflower protein is highlighted as a potentially disruptive technology due to its unique attributes.
Strategic Growth Phases
Burcon outlined a phased approach for growth, from building production capability to scaling and licensing technology.
---
TSE:BU Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:BU Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 14, 2024 | C$0.12 | C$0.12 | +3.48% |
| Aug 14, 2024 | C$0.16 | C$0.16 | 0.00% |
| Jun 26, 2024 | C$0.19 | C$0.18 | -4.74% |
| Feb 14, 2024 | C$0.18 | C$0.17 | -8.84% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Burcon Nutrascience (TSE:BU) report earnings?
Burcon Nutrascience (TSE:BU) is schdueled to report earning on Feb 18, 2025, TBA Not Confirmed.
What is Burcon Nutrascience (TSE:BU) earnings time?
Burcon Nutrascience (TSE:BU) earnings time is at Feb 18, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:BU EPS forecast?
TSE:BU EPS forecast for the fiscal quarter 2025 (Q3) is >-0.01.
---